Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study
Mazyar Shadman, Beenish S. Manzoor, Kavita Sail, Hande H. Tuncer, John N. Allan, Chaitra S. Ujjani, Nnadozie Emechebe, Rajesh Kamalakar, Catherine C. Coombs, Lori A. Leslie, Paul M. Barr, Jennifer R. Brown, Toby A. Eyre, Alexandros Rampotas, Anna Schuh, Nicole Lamanna, Alan P Skarbnik, Lindsey E. Roeker, Rajat Bannerji, Barbara Eichhorst, Isabelle Fleury, Matthew S. Davids, Hasan Alhasani, Dingfeng Jiang, Brian T. Hill, Stephen J. Schuster, Danielle M. Brander, Irina Pivneva, Rebecca Burne, Annie Guerin, Anthony R. Mato
Topics & Concepts
VenetoclaxDiscontinuationMedicineInternal medicineAdverse effectRegimenChronic lymphocytic leukemiaPediatricsLeukemiaChronic Lymphocytic Leukemia ResearchEconomic and Financial Impacts of CancerHealth, Education, and Cultural Studies